• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDM2基因多态性对肉瘤风险的影响。

Impact of MDM2 gene polymorphism on sarcoma risk.

作者信息

Zhang Dawei, Ding Yuanyuan, Wang Zhenlin, Wang Yan, Zhao Guangyue

机构信息

Department of Orthopedics, Xi Jing Hospital, The Fourth Military Medical University, Xi'an, 710032, China.

出版信息

Tumour Biol. 2015 Mar;36(3):1791-5. doi: 10.1007/s13277-014-2781-4. Epub 2014 Nov 4.

DOI:10.1007/s13277-014-2781-4
PMID:25366142
Abstract

A T>G single nucleotide polymorphism (SNP, rs2279744) of the MDM2 gene has been investigated in sarcoma community, but the findings are conflicting. This study was designed to well define the relationship between SNP rs2279744 and sarcoma risk. We did a systematic computerized search of the PubMed, Web of Science, and Science Direct databases to identify the human case-control studies investigating the relationship between SNP rs2279744 and sarcoma risk with complete genetic data. Pooled odds ratios (ORs) were calculated with the Mantel-Haenszel fixed-effect model or the DerSimonian and Laird random effects model to estimate the risk of sarcoma. Overall analysis included five independent studies. On the whole, the T/G genotype or the combined G/G and T/G genotypes appeared to be associated with approximately 1.40-fold higher risk of sarcoma relative to the T/T genotype (T/G vs. T/T: OR 1.33, 95% CI 1.00-1.77; G/G + T/G vs. T/T: OR 1.42, 95% CI 1.08-1.85). We noted that the Caucasian populations showed a similarly increased risk of sarcoma ascribed to the carriage of the same genotypes (T/G vs. T/T: OR 1.41, 95% CI 1.05-1.90; G/G + T/G vs. T/T: OR 1.49, 95% CI 1.13-1.97). This meta-analysis provides evidence that MDM2 SNP rs2279744 may be significantly associated with increased risk of sarcoma in Caucasian individuals.

摘要

MDM2基因的一个T>G单核苷酸多态性(SNP,rs2279744)已在肉瘤领域进行了研究,但结果相互矛盾。本研究旨在明确SNP rs2279744与肉瘤风险之间的关系。我们对PubMed、科学网和科学Direct数据库进行了系统的计算机检索,以识别研究SNP rs2279744与肉瘤风险关系且具有完整基因数据的人类病例对照研究。采用Mantel-Haenszel固定效应模型或DerSimonian和Laird随机效应模型计算合并比值比(OR),以估计肉瘤风险。总体分析包括五项独立研究。总体而言,相对于T/T基因型,T/G基因型或G/G与T/G合并基因型似乎与肉瘤风险高约1.40倍相关(T/G与T/T比较:OR 1.33,95%CI 1.00-1.77;G/G + T/G与T/T比较:OR 1.42,95%CI 1.08-1.85)。我们注意到,白种人群中,相同基因型的携带也显示出类似的肉瘤风险增加(T/G与T/T比较:OR 1.41,95%CI 1.05-1.90;G/G + T/G与T/T比较:OR 1.49,95%CI 1.13-1.97)。这项荟萃分析提供了证据,表明MDM2 SNP rs2279744可能与白种人个体肉瘤风险增加显著相关。

相似文献

1
Impact of MDM2 gene polymorphism on sarcoma risk.MDM2基因多态性对肉瘤风险的影响。
Tumour Biol. 2015 Mar;36(3):1791-5. doi: 10.1007/s13277-014-2781-4. Epub 2014 Nov 4.
2
[Association of murine double minute 2 and P53 polymorphisms with breast cancer susceptibility].[小鼠双微体2与P53基因多态性与乳腺癌易感性的关联]
Zhonghua Yu Fang Yi Xue Za Zhi. 2013 Feb;47(2):124-8.
3
MDM2 rs2279744 polymorphism and endometrial cancer: a meta-analysis.MDM2基因rs2279744多态性与子宫内膜癌:一项荟萃分析
Tumour Biol. 2014 Apr;35(4):3167-70. doi: 10.1007/s13277-013-1413-8. Epub 2013 Nov 30.
4
The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis.功能性 MDM2 T309G 遗传变异而非 P53 Arg72Pro 多态性与肉瘤风险相关:一项荟萃分析。
J Cancer Res Clin Oncol. 2012 Apr;138(4):555-61. doi: 10.1007/s00432-011-1124-8. Epub 2011 Dec 29.
5
The MDM2 SNP309T>G polymorphism increases bladder cancer risk among Caucasians: a meta-analysis.MDM2基因SNP309T>G多态性增加白种人患膀胱癌的风险:一项荟萃分析。
Asian Pac J Cancer Prev. 2014;15(13):5277-81. doi: 10.7314/apjcp.2014.15.13.5277.
6
MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients.MDM2 和 CDKN1A 基因多态性与非洲和高加索患者卡波西肉瘤的风险。
Biomarkers. 2011 Feb;16(1):42-50. doi: 10.3109/1354750X.2010.525664. Epub 2010 Oct 28.
7
Association of MDM2 gene SNP 309 polymorphism and human non-small cell lung cancer susceptibility: A meta-analysis.MDM2 基因 SNP309 多态性与人类非小细胞肺癌易感性的关联:一项荟萃分析。
Pathol Res Pract. 2019 Sep;215(9):152538. doi: 10.1016/j.prp.2019.152538. Epub 2019 Jul 13.
8
Genetic polymorphisms of TP53 (rs1042522) and MDM2 (rs2279744) and colorectal cancer risk: An updated meta-analysis based on 59 case-control studies.TP53(rs1042522)和 MDM2(rs2279744)基因多态性与结直肠癌风险的关系:基于 59 项病例对照研究的更新荟萃分析。
Gene. 2020 Apr 15;734:144391. doi: 10.1016/j.gene.2020.144391. Epub 2020 Jan 27.
9
Associations between the MDM2 promoter P1 polymorphism del1518 (rs3730485) and incidence of cancer of the breast, lung, colon and prostate.MDM2基因启动子P1多态性del1518(rs3730485)与乳腺癌、肺癌、结肠癌和前列腺癌发病率之间的关联。
Oncotarget. 2016 May 10;7(19):28637-46. doi: 10.18632/oncotarget.8705.
10
Association between the MDM2 T309G polymorphism and leukemia risk: a meta-analysis.MDM2基因T309G多态性与白血病风险的关联:一项荟萃分析。
Asian Pac J Cancer Prev. 2014;15(16):6767-72. doi: 10.7314/apjcp.2014.15.16.6767.

引用本文的文献

1
Genetic susceptibility to bone and soft tissue sarcomas: a field synopsis and meta-analysis.骨肉瘤和软组织肉瘤的遗传易感性:领域概述与荟萃分析。
Oncotarget. 2018 Apr 6;9(26):18607-18626. doi: 10.18632/oncotarget.24719.

本文引用的文献

1
Ewing Sarcoma: influence of TP53 Arg72Pro and MDM2 T309G SNPs.尤因肉瘤:TP53 Arg72Pro 和 MDM2 T309G SNP 的影响。
Mol Biol Rep. 2013 Aug;40(8):4929-34. doi: 10.1007/s11033-013-2593-4. Epub 2013 May 10.
2
The functional MDM2 T309G genetic variant but not P53 Arg72Pro polymorphism is associated with risk of sarcomas: a meta-analysis.功能性 MDM2 T309G 遗传变异而非 P53 Arg72Pro 多态性与肉瘤风险相关:一项荟萃分析。
J Cancer Res Clin Oncol. 2012 Apr;138(4):555-61. doi: 10.1007/s00432-011-1124-8. Epub 2011 Dec 29.
3
MDM2 and CDKN1A gene polymorphisms and risk of Kaposi's sarcoma in African and Caucasian patients.
MDM2 和 CDKN1A 基因多态性与非洲和高加索患者卡波西肉瘤的风险。
Biomarkers. 2011 Feb;16(1):42-50. doi: 10.3109/1354750X.2010.525664. Epub 2010 Oct 28.
4
Effect of TP53 Arg72Pro and MDM2 SNP309 polymorphisms on the risk of high-grade osteosarcoma development and survival.TP53基因Arg72Pro多态性和MDM2基因SNP309多态性对高级别骨肉瘤发生风险及生存的影响。
Clin Cancer Res. 2009 May 15;15(10):3550-6. doi: 10.1158/1078-0432.CCR-08-2249.
5
p53 polymorphisms: cancer implications.p53基因多态性:对癌症的影响
Nat Rev Cancer. 2009 Feb;9(2):95-107. doi: 10.1038/nrc2584.
6
Combined effects of MDM2 SNP 309 and p53 mutation on oral squamous cell carcinomas associated with areca quid chewing.MDM2基因单核苷酸多态性309与p53突变对槟榔咀嚼相关口腔鳞状细胞癌的联合影响
Oral Oncol. 2009 Jan;45(1):16-22. doi: 10.1016/j.oraloncology.2008.03.006. Epub 2008 May 19.
7
The single-nucleotide polymorphism 309 in the MDM2 gene contributes to the Li-Fraumeni syndrome and related phenotypes.MDM2基因中的单核苷酸多态性309与李-弗劳梅尼综合征及相关表型有关。
Eur J Hum Genet. 2007 Jan;15(1):110-4. doi: 10.1038/sj.ejhg.5201715. Epub 2006 Sep 27.
8
Unleashing the power of p53: lessons from mice and men.释放p53的力量:来自小鼠和人类的启示。
Genes Dev. 2006 Jan 15;20(2):125-31. doi: 10.1101/gad.1397506.
9
A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints.二元终点对照试验Meta分析中研究规模效应的修正检验。
Stat Med. 2006 Oct 30;25(20):3443-57. doi: 10.1002/sim.2380.
10
The MDM2 promoter polymorphism SNP309T-->G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck.MDM2启动子多态性SNP309T→G与子宫平滑肌肉瘤、结直肠癌及头颈部鳞状细胞癌的风险
J Med Genet. 2005 Sep;42(9):694-8. doi: 10.1136/jmg.2005.031260.